Education
About Us
Working with TipRanks
Follow Us
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
HRMY Analyst Ratings
Moderate Buy
3 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HRMY Stock 12 Month Forecast
Average Price Target
$48.25
▲(40.30% Upside)
| Highest Price Target$55.00 | Average Price Target$48.25 | Lowest Price Target$42.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$46→$50
Buy
45.39%
Upside
Reiterated
02/19/26
Truist Financial
Hold
―
Downgraded
02/19/26
UBS
$43→$46
Hold
33.76%
Upside
Downgraded
02/12/26
H.C. Wainwright
$70→$55
Buy
59.93%
Upside
Reiterated
01/13/26
Needham
$42
Buy
22.13%
Upside
Reiterated
01/12/26
Bank of America Securities
$31→$32
Sell
-6.95%
Downside
Reiterated
11/04/25
Deutsche Bank
$54→$36
Buy
4.68%
Upside
Reiterated
09/25/25
Piper Sandler
$48
Buy
39.58%
Upside
Reiterated
09/25/25
Cantor Fitzgerald
$54→$50
Buy
45.39%
Upside
Reiterated
09/24/25
Oppenheimer
$70→$62
Buy
80.28%
Upside
Reiterated
09/24/25
Goldman Sachs
$33
Hold
-4.04%
Downside
Initiated
07/10/25
LifeSci Capital
$61
Buy
77.38%
Upside
Reiterated
04/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$46→$50
Buy
45.39%
Upside
Reiterated
02/19/26
Truist Financial
Hold
―
Downgraded
02/19/26
UBS
$43→$46
Hold
33.76%
Upside
Downgraded
02/12/26
H.C. Wainwright
$70→$55
Buy
59.93%
Upside
Reiterated
01/13/26
Needham
$42
Buy
22.13%
Upside
Reiterated
01/12/26
Bank of America Securities
$31→$32
Sell
-6.95%
Downside
Reiterated
11/04/25
Deutsche Bank
$54→$36
Buy
4.68%
Upside
Reiterated
09/25/25
Piper Sandler
$48
Buy
39.58%
Upside
Reiterated
09/25/25
Cantor Fitzgerald
$54→$50
Buy
45.39%
Upside
Reiterated
09/24/25
Oppenheimer
$70→$62
Buy
80.28%
Upside
Reiterated
09/24/25
Goldman Sachs
$33
Hold
-4.04%
Downside
Initiated
07/10/25
LifeSci Capital
$61
Buy
77.38%
Upside
Reiterated
04/08/25
Best Analysts Covering Harmony Biosciences Holdings
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+3.02%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +3.02% per trade.
1 Year
Success Rate
12/13 ratings generated profit
Average Return
+13.06%
a rating ―
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +13.06% per trade.
2 Years
xxx
Success Rate
12/13 ratings generated profit
Average Return
+13.14%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +13.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HRMY Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
9
10
5
4
2
Buy
13
13
12
12
8
Hold
0
0
0
0
2
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
0
total
23
25
18
17
12
Each month's total comprises the sum of three months' worth of ratings.
HRMY Financial Forecast
HRMY Stock Forecast FAQ
What is HRMY’s average 12-month price target, according to analysts?
Based on analyst ratings, Harmony Biosciences Holdings’s 12-month average price target is 48.25.
What is HRMY’s upside potential, based on the analysts’ average price target?
Harmony Biosciences Holdings has 40.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HRMY a Buy, Sell or Hold?
Harmony Biosciences Holdings has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings.
What is Harmony Biosciences Holdings’s price target?
The average price target for Harmony Biosciences Holdings is 48.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $55.00 ,the lowest forecast is $42.00. The average price target represents 40.30% Increase from the current price of $34.39.
The highest analyst price target is $55.00 ,the lowest forecast is $42.00. The average price target represents 40.30% Increase from the current price of $34.39.
What do analysts say about Harmony Biosciences Holdings?
Harmony Biosciences Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of HRMY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.